Miller Anestesia

137. Curatalo M, Petersen-Felix S, Arendt-Nielson L, et

al: Epidural epinephrine and clonidine, segmental

analgesia and effects on different pain modalities.

Anesthesiology 87:785–794, 1997.

138. Paech MJ: Patient controlled epidural analgesia in

obstetrics. Int J Obstet Anesth 5:115–125, 1996.

139. Baxi LV, Petrie RH, James LS: Human fetal oxygena-

tion following paracervical block. Am J Obstet

Gynecol 135:1109–1112, 1979.

140. Shnider SM, Asling JH, Holl JW, et al: Paracervical

block anesthesia in obstetrics: I. Fetal complications

and neonatal morbidity. Am J Obstet Gynecol

107:619–625, 1970.

141. Asling JH, Shnider SM, Margolis AJ, et al: Paracer-

vical block anesthesia in obstetrics: II. Etiology of

fetal bradycardia following paracervical block. Am J

Obstet Gynecol 107:626–634, 1970.

142. Klink EW: Perineal nerve block: An anatomic and

clinical study in the female. Obstet Gynecol 1:137–

146, 1953.

143. Hutchins CJ: Spinal anesthesia for instrumental

delivery: A comparison with pudendal nerve block.

Anaesthesia 35:376–377, 1980.

144. Leighton BL, Halpern SH, Wilson DB: Lumbar sym-

pathetic blocks speed early and second stage

induced labor in nulliparous women. Anesthesio-

logy 90:1039–1046, 1999.

145. Albaladejo P, Bouaziz H, Benhamou D: Epidural

analgesics: How can safety and efficacy be impro-

ved? CNS Drugs 10:91–104, 1998.

146. Poppers PJ: Evaluation of local anesthetic agents for

regional anesthesia in obstetrics. Br J Anaesth

47(Suppl):322–327, 1975.

147. Albright G: Cardiac arrest following regional anes-

thesia with etidocaine or bupivacaine. Anesthesio-

logy 51:285–287, 1979.

148. Heath ML: Deaths after intravenous regional anaes-

thesia. BMJ 285:913–994, 1982.

149. Aberg G: Toxicological and local anaesthetic effects

of optically active isomers of 2 local anaesthetic

compounds. Acta Pharmacol Toxicol 31:273–286,

1972.

150. Luduena FP, Bogado EF, Tullar BF: Optical isomers

of mepivacaine and bupivacaine. Arch Int Pharma-

codyn 200:359–369, 1972.

151. BrownWU, Bell GC, Lurie AL, et al: Newborn blood

levels of lidocaine and mepivacaine in the first post-

natal day following maternal epidural anesthesia.

Anesthesiology 42:698–707, 1975.

152. Scanlon JW, Brown WJ Jr, Weiss JB, et al: Neurobe-

havioral responses of newborn infants after mater-

nal epidural anaesthesia. Anesthesiology 40:121,

1974.

153. Kunhert BR, Harrison MJ, Linn PL, et al: Effects of

maternal epidural anesthesia on neonatal behavior.

Anesth Analg 63:301, 1984.

154. Pollock JE, Neal JM, Stephenson CA, et al: Prospec-

tive study of the incidence of transient radicular

irritation in patients undergoing spinal anesthesia.

Anesthesiology 84:1361–1367, 1996.

155. Kuhnert BR, Kuhnert PM, Philipson EH, et al: The

half life of 2-chloroprocaine. Anesth Analg 65:273,

1986.

156. Karambelkar DJ, Ramanathan S: 2-Chloroprocaine

antagonism of epidural morphine analgesia. Acta

Anaesthesiol Scand 41:774–778, 1997.

157. Coda B, Bausch S, Haas M, et al: The hypothesis that

antagonism of fentanyl analgesia by 2 chloropro-

caine is mediated by direct action on opioid recep-

tors. Reg Anesth 22:43–52, 1997.

158. Corke BC, Carlson CG, Dettbarn W: The influence of

2-chloroprocaineonthesubsequentanalgesicpotency

of bupivacaine. Anesthesiology 60:25–27, 1984.

159. Reisner LS, Hochman BN, Plumer MH: Persistent

neurologic deficit and adhesive arachnoiditis

following intrathecal 2-chloroprocaine injection.

Anesth Analg 59:452, 1980.

160. Gissen AJ, Datta S, Lambert D: The chloroprocaine

controversy: I. A hypothesis to explain the neural

complications of chloroprocaine epidural. Reg

Anesth 9:124, 1984.

161. Winnie AP, Nader AM: Santayana’s prophecy fulfi-

lled. Reg Anesth Pain Med 26:558–564, 2001.

162. Yoos JK, Kopacz DJ: Spinal 2-chloroprocaine for

surgery: An initial 10-month experience. Anesth

Analg 100:553–558, 2005.

163. Gristwood RW, Greaves JL: Levobupivacaine: A new

safer long-acting local anaesthetic agent. Exp Opin

Invest Drug 8:861–876, 1999.

164. Bader AM, Tsen LC, Camann WR, et al: Clinical

effects and maternal and fetal plasma concentra-

tions of 0.5% epidural levobupivacaine versus bupi-

vacaine for cesarean delivery. Anesthesiology

90:1596–1601, 1999.

165. Cheng CR, Su TH, Hung YC, et al: A comparative

study of the safety and efficacy of 0.5% levobupiva-

caine and 0.5% bupivacaine for epidural anesthesia

in subjects undergoing elective caesarean section.

Acta Anaesthesiol Sin 40:13–20, 2002.

166. Burke D, Henderson DJ, Simpson A, et al: Compa-

rison of 0.25% S(−) bupivacaine with 0.25% R-S

bupivacaine for epidural analgesia in labour. Br J

Anaesth 83:750–755, 1999.

167. Robinson AP, Lyons GR, Wilson RC, et al: Levobu-

pivacaine for epidural analgesia in labor: The

sparing effect of epidural fentanyl. Anesth Analg

92:410–414, 2001.

168. Stienstra R, Tonker TV, Bourdez P: Ropivacaine

0.25% versus bupivacaine 0.25% for continuous epi-

dural analgesia in labor: A double-blind compari-

son. Anesth Analg 80:285–289, 1995.

169. Capogna G, Celleno D, Fusco P, et al: Relative poten-

cies of bupivacaine and ropivacaine for analgesia in

labour. Br J Anaesth 82:371–373, 1999.

170. Hamilton BE, Martin JA, Ventura SJ, et al: Births.

Preliminary data for 2004. Natl Vital Stat Rep 54(8),

2005.

171. Depp R: Cesarean delivery and other surgical pro-

cedures.

Gabbe SG, Niebyl JR, Simpson JL (eds):

Obstetrics: Normal and Problem Pregnancies. New

York, Churchill Livingstone, 1991, p 635.

172. NIH State of the Science Conference Statement.

Cesarean Delivery on Maternal request. NIH

Consens State Sci Statements 231-29, 2006.

173. Hawkins JL, Gibbs CP, Orleans M, et al: Obstetric

anesthesia work force survey, 1981 versus 1992.

Anesthesiology 87:135–143, 1997.

174. Andrews WW, Ramin SM, Maberry MC, et al: Effect

of type of anesthesia on blood loss at elective repeat

cesarean section. Am J Perinatol 9:197–200, 1992.

175. Riley ET, Cohen SE, Macario A, et al: Spinal versus

epidural anesthesia for cesarean section: A compa-

rison of time efficiency, costs, charges, and compli-

cations. Anesth Analg 80:709–712, 1995.

176. Norris MC: Height, weight and the spread of suba-

rachnoid hyperbaric bupivacaine in the term partu-

rient. Anesth Analg 67:555, 1988.

177. De Simone CA, Leighton BL, Norris MC: Spinal

anesthesia for cesarean delivery: A comparison of

two doses of hyperbaric bupivacaine. Reg Anesth

20:90, 1995.

178. Vucevic M, Russell IF: Spinal anesthesia for caesa-

rean section: 0.125% plain bupivacaine 12 mL com-

pared with 0.5% plain bupivacaine 3 mL. Br J

Anaesth 68:590–595, 1992.

179. Runza M, Albani A, Tagliabue M, et al: Spinal anes-

thesia using 3 ml hyperbaric 0.75% versus hyperba-

ric 1% bupivacaine for cesarean section. Anesth

Analg 87:1099–1103, 1998.

180. Hamza J, Mohammed S, Benhamou D, et al:

Parturient’s posture during epidural puncture affects

the distance from the skin to epidural space. J Clin

Anesth 7:1–4, 1995.

181. Russell IF: Spinal anaesthesia for caesarean section:

The use of 0.5% bupivacaine. Br J Anaesth 55:309–

314, 1983.

182. Abouleish EI: Epinephrine improves the quality of

spinal hyperbaric bupivacaine for cesarean section.

Anesth Analg 66:395, 1987.

183. Abouleish E, Rawal N, Fallon K, et al: Combined

intrathecal morphine and bupivacaine for cesarean

section. Anesth Analg 67:370, 1988.

184. Dahlgren G, Hultstrand C, Jakobsson J, et al: Intra-

thecal sufentanil, fentanyl or placebo added to bupi-

vacaine for cesarean section. Anesth Analg

85:1288–1293, 1997.

185. Di Fazio CA, Carron H, Grosslight RR, et al: Com-

parison of pH-adjusted lidocaine solutions for epi-

dural anesthesia. Anesth Analg 65:760–764, 1986.

186. Benhamou D, Labaille T, Bonhomme L, et al: Alka-

linization of epidural 0.5% bupivacaine for cesarean

section. Reg Anesth 14:240–243, 1980.

187. Lam DT, Ngan Kee WD, Khaw KS: Extension of

epidural blockade in labour for emergency caesa-

rean section using 2% lidocaine with epinephrine

and fentanyl, with or without alkalinization. Anaes-

thesia 56:790–794, 2001.

188. Laishley RS, Morgan BM: A single dose epidural tech-

nique for caesarean section: A comparison between

0.5% bupivacaine plain and 0.5% bupivacaine with

adrenaline. Anaesthesia 43:100–103, 1988.

189. Preston PG, Rosen MA, Hughes SC, et al: Epidural

anesthesia with fentanyl and lidocaine for cesarean

section: Maternal effects and neonatal outcome.

Anesthesiology 68:938, 1988.

190. Vertommen JD, Van Aken H, Vandermeulen E, et al:

Maternal and neonatal effects of adding epidural

sufentanil to 0.5% bupivacaine for cesarean delivery.

J Clin Anesth 3:371–376, 1991.

191. Eisanach J, Detweiler D, Hood D: Hemodynamic

and analgesic actions of epidurally administered

clonidine. Anesthesiology 78:277–287, 1993.

192. Carrie LES, O’Sullivan GM: Subarachnoid bupiva-

caine 0.5% for cesarean section. Eur J Anaesthesiol

1:275–283, 1984.

193. Crowhurst J, Birnbach DJ: Low dose neuraxial

block: Heading towards the new millennium.

Anesth Analg 90:241–242, 2000.

194. Blumgart CH, Ryall D, Dennison B, et al: Mechanism

of extension of spinal anaesthesia by extradural injec-

tion of local anesthetic. Br J Anaesth 69:457, 1992.

195. Lim Y, Teoh W, Sia AT: Combined spinal epidural

does not cause a higher sensory block than single

shot spinal technique for cesarean delivery in labo-

ring women. Anesth Analg 103:1540–1542, 2006.

196. Rawal N, Van Zunder A, Holmstrom B, et al: Com-

bined spinal-epidural technique. Reg Anesth

22:406–423, 1997.

197. Hurley RJ, Lambert DH: Continuous spinal anesthe-

sia with a microcatheter technique: Preliminary

experience. Anesth Analg 70:97–102, 1990.

198. Kuczkowski KM, Benumof JL: Decrease in the inci-

dence of post-dural puncture headache: Maintai-

ning CSF volume. Acta Anaesthesiol Scand

47:98–100, 2003.

199. Hawkins JL, Koonin LM, Palmer SK, et al: Anesthe-

sia-related deaths during obstetric delivery in the

United States, 1979-1990. Anesthesiology 86:277–

284, 1999.

200. Morgan M: Anaesthetic contribution to maternal

mortality. Br J Anaesth 59:842–855, 1987.

201. Rocke DA, Murray WB, Rout CC, et al: Relative risk

analysis of factors associated with difficult intuba-

tion in obstetric anesthesia. Anesthesiology 77:67,

1992.

202. Farcon EL, Kim MH, Marx GF: Changing Mallam-

pati score during labor. Can J Anaesth 41:50–51,

1994.

203. Myhre JM, Riesner MN, Polley LS, et al: A series of

anesthesia-related maternal deaths in Michigan

1985-2003. Anesthesiology 106:1096–1104, 2007.

204. Report on Confidential Enquiries into Maternal

Deaths in the United Kingdom 1985-87. London,

Her Majesty’s Stationery Office, 1987.

205. Brown GW, Russell IF: A survey of anaesthesia for

caesarean section. Int J Obstet Anesth 4:214–218,

1995.

206. Norris MC: Hypotension during spinal anesthesia

for cesarean section: Does it affect neonatal

outcome? Reg Anesth 12:191, 1987.

207. Tsen LC, Boosalis P, Segal S, et al: Hemodynamic

effects of simultaneous administration of intrave-

nous ephedrine and spinal anesthesia for cesarean

delivery. J Clin Anesth 12:378–382, 2000.

208. Ngan Kee WD, Khaw K, Lee BB, et al: A dose-res-

ponse study of prophylactic intravenous ephedrine

for the prevention of hypotension during spinal

anesthesia for cesarean delivery. Analg Analg

90:1390–1395, 2000.

2004

Anestesia por subespecialidades en el adulto